C62.12 - Malignant neoplasm of descended left testis

Version 2023
ICD-10:C62.12
Short Description:Malignant neoplasm of descended left testis
Long Description:Malignant neoplasm of descended left testis
Status: Valid for Submission
Version:ICD-10-CM 2023
Code Classification:
  • Neoplasms (C00–D48)
    • Malignant neoplasms of male genital organs (C60-C63)
      • Malignant neoplasm of testis (C62)

C62.12 is a billable ICD-10 code used to specify a medical diagnosis of malignant neoplasm of descended left testis. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.

This code is applicable to male patients only. It is clinically and virtually impossible to use this code on a non-male patient.

The following anatomical sites found in the Table of Neoplasms reference the parent code C62.1 of the current diagnosis code given the correct histological behavior: Neoplasm, neoplastic testis, testes descended or Neoplasm, neoplastic testis, testes scrotal .

Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:

Convert to ICD-9 Code

Source ICD-10 CodeTarget ICD-9 Code
C62.12186.9 - Malig neo testis NEC
Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Table of Neoplasms

The parent code C62.1 of the current diagnosis code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »testis, testes
    »descended
C62.1C79.82D07.69D29.2D40.1D49.59
»Neoplasm, neoplastic
  »testis, testes
    »scrotal
C62.1C79.82D07.69D29.2D40.1D49.59

Patient Education


Testicular Cancer

Testicles, or testes, make male hormones and sperm. They are two egg-shaped organs inside the scrotum, the loose sac of skin behind the penis. You can get cancer in one or both testicles.

Testicular cancer mainly affects young men between the ages of 20 and 39. It is also more common in men who:

Symptoms include pain, swelling, or lumps in your testicles or groin area. Doctors use a physical exam, lab tests, imaging tests, and a biopsy to diagnose testicular cancer. Most cases can be treated, especially if found early. Treatment options include surgery, radiation, and/or chemotherapy. Regular exams after treatment are important.

Treatments may also cause infertility. If you may want children later on, you should consider sperm banking before treatment.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History